Oramed Pharmaceuticals, Inc. (ORMP)
3.455
+0.14
(+4.38%)
USD |
NASDAQ |
Feb 24, 16:00
3.455
0.00 (0.00%)
After-Hours: 19:39
Oramed Pharmaceuticals Research and Development Expense (Quarterly) : 1.153M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Lifeward Ltd. | 0.721M |
| Bristol Myers Squibb Co. | 2.561B |
| Merck & Co., Inc. | 3.992B |
| Instil Bio, Inc. | 9.127M |
| Moderna, Inc. | 708.00M |